Literature DB >> 6176371

beta 2-Microglobulin instability in pathological urine.

P G Davey, P Gosling.   

Abstract

Urinary excretion of beta 2-microglobulin (beta 2M) is a widely used test of renal proximal tubular function. beta 2M is known to be unstable in normal urine with a pH less than 5.5. The results of a study of beta 2M excretion in patients receiving gentamicin suggested that beta 2M might be more unstable in pathological urine. A series of experiments was designed to define the extent, variability, and mechanism of its instability in pathological urine. It was unstable in pathological urine with a pH of 6.0 at 37 degrees C and pH 5.5 at room temperature, but this varied in urines from different patients. The instability was abolished by heating the urine to 80 degrees C. These results suggest that the most likely explanation for the instability is enzymic degradation. Because enzymuria will vary among patients, investigators should test the stability of beta 2M in urine from the patients they wish to study before trying to define conditions for urine collection.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6176371

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  21 in total

1.  Urinary alpha 1-microglobulin as an index of proximal tubular function in early infancy.

Authors:  H Tsukahara; M Hiraoka; M Kuriyama; M Saito; K Morikawa; M Kuroda; T Tominaga; M Sudo
Journal:  Pediatr Nephrol       Date:  1993-04       Impact factor: 3.714

2.  Beta 2-glycoprotein-1 (apolipoprotein H) excretion in chronic renal tubular disorders: comparison with other protein markers of tubular malfunction.

Authors:  M Lapsley; P A Sansom; C T Marlow; F V Flynn; A G Norden
Journal:  J Clin Pathol       Date:  1991-10       Impact factor: 3.411

3.  Effect of protein restriction in insulin dependent diabetics at risk of nephropathy.

Authors:  A Polak; D Rowe
Journal:  Br Med J (Clin Res Ed)       Date:  1987-05-23

4.  Impaired renal tubular function in chronic alcoholics.

Authors:  M Labib; M Abdel-Kader; L Ranganath; S Martin; V Marks
Journal:  J R Soc Med       Date:  1989-03       Impact factor: 5.344

Review 5.  Guidelines for treatment of renal injury during cancer chemotherapy 2016.

Authors:  Shigeo Horie; Mototsugu Oya; Masaomi Nangaku; Yoshinari Yasuda; Yasuhiro Komatsu; Motoko Yanagita; Yuko Kitagawa; Hiroyuki Kuwano; Hiroyuki Nishiyama; Chikashi Ishioka; Hiromasa Takaishi; Hideki Shimodaira; Akira Mogi; Yuichi Ando; Koji Matsumoto; Daisuke Kadowaki; Satoru Muto
Journal:  Clin Exp Nephrol       Date:  2018-02       Impact factor: 2.801

6.  Urinary beta 2-microglobulin as a marker for vesicoureteral reflux.

Authors:  F K Assadi
Journal:  Pediatr Nephrol       Date:  1996-10       Impact factor: 3.714

7.  Urinary excretion of beta 2-glycoprotein-1 (apolipoprotein H) and other markers of tubular malfunction in "non-tubular" renal disease.

Authors:  F V Flynn; M Lapsley; P A Sansom; S L Cohen
Journal:  J Clin Pathol       Date:  1992-07       Impact factor: 3.411

Review 8.  Hereditary causes of kidney stones and chronic kidney disease.

Authors:  Vidar O Edvardsson; David S Goldfarb; John C Lieske; Lada Beara-Lasic; Franca Anglani; Dawn S Milliner; Runolfur Palsson
Journal:  Pediatr Nephrol       Date:  2013-01-20       Impact factor: 3.714

9.  [Alpha 1-microglobulin in the urine and serum in proteinuria and kidney insufficiency].

Authors:  M H Weber; P Scholz; W Stibbe; F Scheler
Journal:  Klin Wochenschr       Date:  1985-08-01

Review 10.  Low molecular weight proteins in children with renal disease.

Authors:  P A Tomlinson
Journal:  Pediatr Nephrol       Date:  1992-11       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.